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Pharmacy 553 Therapeutics III: Fall 2008
Lectures:

Tuesday & Thursday 9:10-11:00 SB 117

Course Coordinator:
Instructors:

Material and Resources
Required Texts:

Optional Texts:

Michael Rivey ====>
Douglas Allington
Rose Macklin
Lee Ann Bradley
Sarah Miller
Gayle Hudgins
Donna Beall
Kim Madson
Kendra Keeley

M. Rivey
Office: 243-6796
Community Hosp:
Pager: 329-6122
Home: 251-3369
Cell: 546-5534

327-4299
ext. 7605

DiPiro Pharmacotherapy, 6th edition
APhA: Handbook of Nonprescription Drugs 15th edition
Medical Letter on Drugs & Therapeutics
Goodman & Gilman's Pharmacological Basis of Therapeutics
A medical dictionary
Pagana & Pagana: Diagnostic & Lab Test Ref., or other lab. text
Murphy: Clinical Pharmacokinetics pocket reference
Boh Pharmacy Practice Manual
Evans: Applied Pharmacokinetics
Young, Koda-Kimble: Applied Therapeutics
Herfindal, Gourley, Hart: Clinical Pharmacy and Therapeutics
Hansten & Horn: Drug Interactions

Goals of the Course
To promote the students' understanding of common disease
states with particular emphasis on the facets of diseases
that are amenable to drug therapy.
To familiarize the student with the proper use of drugs in
a clinical setting.
To develop the students' awareness of factors that should be
considered prior to selection of a drug and the appropriate
parameters that should be monitored for therapeutic as well
as undesired effects.
To encourage the students' ability to problem-solve in the
clinical setting.
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Performance Objectives
Upon completion of this course, each student shall be able to:
Relate the pathophysiology of a disease to the known or purported action of a drug.
Evaluate the seriousness of a disorder based on the signs and symptoms related to a
diagnosed problem, and:
--determine the necessity of drug therapy,
--when applicable, choose the proper drug and/or
drug product for the situation.
Determine the place of non-pharmacologic and natural therapies, when applicable.
Tailor the drug therapy of an individual based on patient characteristics and known
pharmacokinetics principles.
Identify potential drug-drug interactions.
Monitor the appropriate parameters of a disease to determine if the patient is responding
positively to therapy.
Monitor for adverse drug reactions and exacerbations of underlying patient problems
resulting from drug therapy.
Student Responsibilities and Obligations
* To attend and participate in lecture sessions.
* To do assigned readings from the texts.
* To attend Integrated Studies conferences, prepare each case in advance, to present a
patient case, and participate in the discussion of all patient presentations.
* To perform satisfactorily on course quizzes and lecture examinations.
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GRADING IN COURSE: Phar 553 Therapeutics III
3 midterm exams: 100 points each
Final exam (comprehensive, multiple choice)
(80 pts comprehensive, 50 pts over new topic lectures)
Topic quizzes: 8 quizzes graded on 10 pts each
TOTAL POINTS FOR COURSE

300 points
130 points
Bonus pts > 75% (60 pts)
430 POINTS

Class quizzes: The purposes of the quizzes are to promote reading of the text before a topic
and encourage class attendance and attention. Quizzes will occur before topic lectures and will
test understanding of basic concepts in the reading assignment, and will cover only
chapter/reading material associated with the day the quiz is scheduled. If there are multiple
chapters or readings, the one for quiz content is indicated.
A quiz will consist of 5 multiple choice or true/false questions, each worth 2 points. QUIZ on
syllabus indicates a quiz will be given for assigned reading at start of the given lecture. Lowest
2 quiz grades will be thrown out; no make-ups will be allowed for quiz. Scoring: Quiz
performance can only benefit student; bonus points for the course will be awarded for all
points over 75% (i.e. 60 pts) of the potential total 80 pts on the quizzes (10 total quizzes – 2
throw-outs = 8x10 pts)
Exams:
3 midterm exams: Tests will be in "traditional" case report fashion with multiple choice/short
answers required. Tests will be given on Thursday late afternoons 4:30-6:30 PM.
Work is not an acceptable excuse for not taking a test during the test time. Any excuse
for missing a test must be approved BEFORE the test is given, and an Agreement for
taking the test at an alternate time will be filed in the Dean’s Office. Calculators may be
required for tests; PDAs are not allowed.
Final exam: 65 multiple choice questions worth 2 pts each. An effort will be made to design
questions in the style similar to what you will encounter on the NAPLEX exam.
Grading:
Grades generally follow closely to 90-100% A; 80-89% B; 70-79% C; 60-69% D, and below 60%
F. Grades may be slightly given on a curve depending on overall students’ performance in
course. We do use the +/- system for grading
UM Statement

All students must practice academic honesty. Academic misconduct is subject to an academic
penalty by the course instructor and/or disciplinary sanction by the University
All students need to be familiar with the Student Conduct Code. The Code is available for
review online at http://www.umt.edu/SA/VPSA/index.cfm/page/1321
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Integrated Studies Conferences: you will be assigned to a conference based on period you
registered for; instructors are not necessarily the ones under which you registered.
Attendance/make-up is required for all topics/cases; you may attend a different conference in
order to complete the assignment, but ONLY with instructor permission. The “make-up”
requirement for a conference missed due to unavoidable incident will be at the discretion of the
instructor, dependent on the topic. Failure to complete any conference will result in a grade of
“fail” for course.

Class civility: Your student colleagues have strongly indicated to us that they wish to spend
their valuable time in class listening to the therapeutics topics. They do not appreciate any
“side” conversations while the instructor is lecturing. They do appreciate students raising
questions about important lecture aspects for further discussion or clarification.
Out of respect for your classmates, we will not tolerate excessive and disruptive talking
during lecture. The instructor may first ask you to be silent; you may be asked to leave class if
you persist in disruptive talking. The instructor will be the judge of “what” constitutes
disruption. Please note that we encourage questions and relevant discussion.
Cell phones must be in the “off” mode during class. Disruption due to the use of cell phones
in class will not be tolerated; this includes cell phones turned to the “vibration” mode.
Policy regarding young children: It may sometimes be necessary for a student to bring their
young child to class, due to school illness policy, daycare provider illness, or off-school days. It
is acceptable to bring a child to class ONLY in those situations. Do not bring an acutely ill child
to class. Please remember that children generally are NOT entertained by a therapeutics
lecture, so provide some activity for them during class.
It is the responsibility of the parent to assure that the child does not disrupt other students.
Reading assignments: Reading assignments as listed in the syllabus are for DiPiro 6th edition
and the Handbook of Nonprescription Drugs 15th edition.
* NOTE: the DiPiro 6th edition was released in summer 2005. Material contained in a
textbook typically is over 1 year old by the time the edition is printed. Please note that when
discrepancies arise between what the professor presents in lecture and what is contained in the
textbook, the content provided in class is more current- we strive to present the most current
information vs. what is contained in a textbook.
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Therapeutics 553 Pharm.D.: Lecture Syllabus
Instructor

Reading

Aug

26 T
28 Th

Introduction/ Liver disease
Liver disease

MPR
MPR

40
37

Sept

2
4

Renal disease/ QUIZ
Renal Disease

DRA
DRA

41, 42
43, 44, pp 851-61

9T
11 Th

Pain management/ QUIZ
Headache

LAB
DGB

60
59, OTC 5

16 T
18 Th-1
18 Th-1

Contraception/ QUIZ
Contraception
Urinary Disorders

DGB
DGB
DRA

77 (quiz), OTC 10

23 T
25 Th
25 Th

Menopause/ QUIZ
GAH
80
Osteoporosis
GAH
88, OTC 459-460
Test 1 at 4:30-6:30 PM; through urinary disorders

30 T-1
30 T-2
2 Th

no class, in lieu of test 1
Arthritis
Arthritis/ QUIZ

MPR
MPR

90, OTC 72-83
89 (quiz)

7 T-1
7 T-2
9 Th

Gout
Fluid & electrolytes
F &E

MPR
SJM
SJM

91
pp 937-50; 967-76
pp 950-63; 976-80

14 T

Nutrition support/ QUIZ

SJM

16 Th

Nutrition support

SJM

pp 2559-64; 2569-72 ;
2591-8
pp 2598-2611; 138

21 T
23 Th
23 Th

Oncology/ QUIZ
KAM
TBA
Oncology
KAM
Test 2 at 4:30-6:30 PM; through Nutrition Support

28T
30 Th

Oncology
Nausea & Vomiting

4T
6 Th

ELECTION DAY: off (in lieu of test 2)

11 T
13 Th-1
13 Th-2

VETERANS DAY: off (in lieu of test 3)

Oct

Nov

Asthma

Respiratory pharmacotherapy
COPD/ QUIZ

553-Ther III, continued

83, OTC 52

KAM
LAB

35, OTC 20

KAK

26

KAK
DRA

25, OTC 13
27

Instructor
Nov

Dec

Reading

18 T-1
18 T-2
20 Th-1
20 Th-2
20 Th

COPD
DRA
Thromboembolic disease/ QUIZ
MPR
TED
MPR
Stroke
MPR
Test 3 at 4:30-6:30 PM ; through COPD

25 M *
27 Th

Diabetes mellitus/ QUIZ
OFF: THANKSGIVING HOLIDAY

LRM

72

Diabetes mellitus
CLASS EVALUATION
Thyroid disease

LRM

OTC 47

MPR

73

2T
4 Th

19
20

Final, Dec 10 at 1010-1200: test 4, 130 pts comprehensive multiple choice

6

